Boc-NH-PEG3
CAS No. 139115-92-7
Boc-NH-PEG3( PROTAC Linker 10 )
Catalog No. M20918 CAS No. 139115-92-7
Boc-NH-PEG3 is a PEG derivative containing a hydroxyl group and Boc-protected amino group and is a PROTAC linker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 27 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBoc-NH-PEG3
-
NoteResearch use only, not for human use.
-
Brief DescriptionBoc-NH-PEG3 is a PEG derivative containing a hydroxyl group and Boc-protected amino group and is a PROTAC linker.
-
DescriptionBoc-NH-PEG3 is a PEG derivative containing a hydroxyl group and Boc-protected amino group and is a PROTAC linker.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
SynonymsPROTAC Linker 10
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPROTAC Linker
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number139115-92-7
-
Formula Weight249.3
-
Molecular FormulaC11H23NO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (401.12 mM)
-
SMILESCC(C)(C)OC(=O)NCCOCCOCCO
-
Chemical Nametert-butyl (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sainan An Liwu et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs.[J]. EBioMedicine 2018.
molnova catalog
related products
-
A1874
A1874 (A-1874) is a nutlin-based and BRD4-degrading PROTAC with DC50 of 32 nM (induce BRD4 degradation in cells).
-
Rpn13 degrader WL40
Rpn13 degrader WL40 (WL40) is a novel covalent ubiquitin receptor Rpn13 degrader by linking the Rpn13 covalent inhibitor RA190 with the cereblon (CRBN) binding ligand thalidomide.
-
ARV-771
ARV-771, a small-molecule pan-BET degrader based on proteolysis-targeting chimera (PROTAC) technology, demonstrates dramatically improved efficacy in cellular models of CRPC as compared with BET inhibition.
Cart
sales@molnova.com